PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹190 Cr | ₹190 Cr | ₹145 Cr | ₹153 Cr | ₹106 Cr |
What is the latest Total Liabilities ratio of PARNAX LAB ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹190 Cr |
| Mar2024 | ₹190 Cr |
| Mar2023 | ₹145 Cr |
| Mar2022 | ₹153 Cr |
| Mar2021 | ₹106 Cr |
How is Total Liabilities of PARNAX LAB Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹190 Cr | -0.23 | |
| Mar2024 | ₹190 Cr | 31.15 | |
| Mar2023 | ₹145 Cr | -5.47 | |
| Mar2022 | ₹153 Cr | 44.43 | |
| Mar2021 | ₹106 Cr | - | |
Compare Total Liabilities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹147.5 Cr | 5.3% | 4% | -13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 5.3% |
4% |
-13.9% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses